Can a smartphone app tame your allergies?

NCT ID NCT06603935

ENROLLING_BY_INVITATION Disease control Sponsor: QHSLab, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether digital tools can help people with allergic rhinitis (hay fever) better control their symptoms. About 240 adults will use a smartphone platform that tracks symptoms, sends reminders, and gives personalized advice. Researchers will compare their progress to those receiving standard care over 12 months, looking at symptom severity, medication use, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: QHSLab digital platform (Allergy Management Evaluation and Allergic Rhinitis Intervention Steps)
What this could lead to: If successful, this could provide an effective digital tool to help people better control their allergic rhinitis symptoms and improve daily life.
What could go wrong: This is a relatively small, early-stage study testing a digital tool, not a drug. The tool may not significantly improve outcomes over standard care, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic rhinitis Rhinitis, Allergic sinusitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALLERGIC RHINITIS SINUSITIS

Contacts and locations

Locations

QHSLab

West Palm Beach, Florida, 33407, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.